Navigation Links
FDA Panel Weighs OK of 'Female Viagra'
Date:6/18/2010

Recent research has shown increase in sexual satisfaction, if not libido

FRIDAY, June 18 (HealthDay News) -- A U.S. Food and Drug Administration advisory panel on Friday was considering whether to approve a drug dubbed the "female Viagra" for premenopausal women with a diminished sex drive.

Called flibanserin, the drug is related to the antidepressant family and affects serotonin and other chemicals in the brain. Drug maker Boehringer Ingelheim has been seeking FDA approval of the drug.

While the agency isn't compelled to follow the recommendations of its advisory panels, it typically does so.

Earlier this week, the FDA released a review of two studies that found the drug didn't have much impact on a woman's libido but did seem to slightly boost sexual satisfaction, according to published reports.

Side effects seen with use of the drug included depression, fainting and dizziness, the FDA said.

The drug, with the proposed brand name Girosa, is designed to be taken in 100-milligram pills once a day at bedtime, according to the FDA.

Since the extraordinary success of Viagra for men, which hit the market a decade ago, pharmaceutical companies have repeatedly tried to find a comparable drug treatment for women. But none of those treatments has resulted in a significant benefit.

More information

To learn more about women's sexual health, visit the International Society for the Study of Women's Sexual Health.



-- HealthDay staff



SOURCES: U.S. Food and Drug Administration Web site


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. NFL Brain Injury Panel Raises Awareness of Potential Long-Term Consequences from Traumatic Brain Injuries
2. Panel calls for reducing colorectal cancer deaths by striking down barriers to screening
3. Federal Panel Urges Obesity Screening for Kids Ages 6 and Up
4. Scientific panel evaluates soy infant formula safety
5. Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned
6. PolitiFact Names 'Death Panels' Claim the Lie of the Year
7. Expert Panel Reaches Consensus on Our Ability to Improve Cognitive Health
8. Panel Intelligence Returns to MedPanel Name
9. Panel asks dairy avoiders: Are you getting enough?
10. Avoiding Dairy Due to Lactose Intolerance is Unnecessary in Most Cases and May Pose Diet and Health Risks, Concludes National Institutes of Health Consensus Development Conference Panel
11. All Global Launches Physician Panels in Russia and Poland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... one of the most popular and least understood books in the Holy Scriptures, Revelation. ... descriptions that have baffled scholars for centuries. Many have tossed it off as mere ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the ... published author, William Nowers. Captain Nowers and his wife, Millie, have six children, ... in the Navy. Following his career as a naval aviator and carrier pilot, ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... Maryland (PRWEB) , ... October 12, 2017 , ... ... magnetic drug delivery system that we intend to develop to enable prevention of ... can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
(Date:9/22/2017)... ROCKVILLE, Md. , Sept. 22, 2017  As ... by Republican Senators Bill Cassidy (R-LA) and ... Kalorama Information notes that the medical device industry is ... the medical device tax, the 2.3% excise tax on ... Act.  But they also want covered patients, increased visits ...
(Date:9/19/2017)... 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, ... three leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has ...
Breaking Medicine Technology: